NCT04374617

Brief Summary

Severe COVID-19 patients at a high risk of venous thromboembolism. We studied patients in 2 intensive care units of university hospitals in Barcelona and Badalona, Spain. We performed a cut-off screening of deep venous thrombosis (DVT) with bilateral duplex ultrasound to 230 patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2020

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 5, 2020

Completed
Last Updated

May 6, 2020

Status Verified

May 1, 2020

Enrollment Period

24 days

First QC Date

May 2, 2020

Last Update Submit

May 4, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Venous thromboembolisms

    Patients with symptomatic pulmonary embolism confirmed on the CT-angiography and those with a swollen limb and confirmed deep venous thrombosis on compression ultrasound were considered to have "symptomatic venous thromboembolisms". The remaining patients with positive limb ultrasound or CT-angiography were considered to have "asymptomatic venous thrombembolism"

    7 days

Secondary Outcomes (1)

  • Deaths

    7 days

Study Arms (1)

Venous thromboembolism

Patients at risk of venous thromboembolism (deep venous thrombosis and/or pulmonary embolism)

Diagnostic Test: Duplex ultrasound and Computed Tomography Angiography

Interventions

All venous thromboembolisms suspected will diagnosed with ultrasound and CT-angiography

Also known as: Compression ultrasound (CUS), Ct-Angiography
Venous thromboembolism

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with severe COVID-19 pneumonia admitted to the intensive care unit.

You may qualify if:

  • Patients with severe COVID-19 pneumonia admitted to the intensive care unit

You may not qualify if:

  • Treatment with Extracorporeal membrane oxygenation (ECMO)
  • Pregnant or postpartum women
  • Under 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Vall d´Hebron Research Institute VHIR

Barcelona, Catalonia, 08035, Spain

Location

Hospital Germans Trias i Pujol. Universitat Autònoma de Barcelona

Badalona, 08916, Spain

Location

Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona

Barcelona, 08035, Spain

Location

MeSH Terms

Conditions

COVID-19Critical IllnessVenous ThromboembolismVenous ThrombosisPulmonary EmbolismThrombosisSevere Acute Respiratory Syndrome

Interventions

Ultrasonography, Doppler, DuplexComputed Tomography Angiography

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesEmbolism

Intervention Hierarchy (Ancestors)

Ultrasonography, DopplerUltrasonographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomography, X-Ray ComputedImage Interpretation, Computer-AssistedMultimodal ImagingRadiographic Image EnhancementImage EnhancementPhotographyRadiographyTomography, X-RayTomography

Study Officials

  • Sergi Bellmunt, MD,PhD

    Hospital Vall d'Hebron

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2020

First Posted

May 5, 2020

Study Start

April 1, 2020

Primary Completion

April 25, 2020

Study Completion

May 1, 2020

Last Updated

May 6, 2020

Record last verified: 2020-05

Locations